Truist Securities Maintains Buy on Sabra Health Care REIT, Raises Price Target to $24

Benzinga · 3d ago
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $22 to $24.